24/7 Wall St. on MSN
Triple-leveraged biotech ETF doubles as regulatory winds shift in 2026
Quick Read Direxion Biotech Bull 3X (LABU) doubled over the past year by delivering three times the daily biotech index return. FDA drug approvals often trigger 20% to 50% single-day stock jumps that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results